Skip to main content

Table 4 Thromboembolic events within 14 days of 4F-PCC administration

From: Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors

Thromboembolic event n (%)
Total 1 (2.3)
Deep vein thrombosis 1 (2.3)
Pulmonary embolism 0
Myocardial infarction 0
Cerebral vascular accident 0
Arterial thrombosis of limb 0
Arterial thrombosis of mesenteries 0